Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 16, 2012 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Announces Exercise of Underwriters' Over-Allotment Option and Closing of $14.5 Million Public Offering of Common Stock

LAKE OSWEGO, Ore., April 16, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet...
April 10, 2012 04:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Present at the World Vaccine Trials Congress

LAKE OSWEGO, Ore., April 10, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet...
April 05, 2012 08:37 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Announces Pricing of Public Offering of Common Stock

LAKE OSWEGO, Ore., April 5, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet...
April 04, 2012 16:23 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Announces Public Offering of Common Stock

LAKE OSWEGO, Ore., April 4, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet...
March 28, 2012 18:03 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Reports Fourth Quarter and 2011 Financial Results and Provides Business Update

LAKE OSWEGO, Ore., March 28, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet...
March 21, 2012 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Announces Addition of Renowned Breast Cancer Physician to Its Scientific Advisory Board

LAKE OSWEGO, Ore., March 21, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet...
March 20, 2012 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Strengthens NeuVax(TM) Intellectual Property Position With Notice of Allowance for U.S. Patent

Patent covers the use of NeuVax for treating Phase 3 target population of low-to-intermediate (IHC 1+/2+) HER2 patients. Provides NeuVax exclusivity for this indication until 2028, not...
March 07, 2012 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Present at the 24th Annual ROTH Conference

LAKE OSWEGO, Ore., March 7, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet...
February 29, 2012 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma Announces Expansion of Scientific Advisory Board

LAKE OSWEGO, Ore., Feb. 29, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet...
February 28, 2012 07:05 ET | Source: Galena Biopharma, Inc.

Galena Biopharma to Present at the Cancer Targets and Therapeutics Conference

LAKE OSWEGO, Ore., Feb. 28, 2012 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biotechnology company focused on developing innovative, targeted oncology treatments addressing major unmet...